Clinical risk factors of colorectal cancer in patients with serrated polyposis syndrome

Autor: Gerrit A. Meijer, Y J van Herwaarden, Evelien Dekker, Susan K. Clark, Joep E. G. IJspeert, N. van Lelyveld, M C W Spaander, Jan J. Koornstra, M E van Leerdam, S A Q Rana, Barbara A. J. Bastiaansen, Tanya M. Bisseling, Iris D. Nagtegaal, Andrew Latchford, James E. East, Nathan S. S. Atkinson, Silvia Sanduleanu

Publikováno v: Gut, 66, 2, pp. 278-284
Gut, 66, 278-284
Gut, 66(2), 278-284. BMJ PUBLISHING GROUP
Gut, 66(2), 278-284. BMJ Publishing Group

Contains fulltext : 169924pub.pdf (Publisher’s version ) (Closed access) OBJECTIVE: Serrated polyposis syndrome (SPS) is accompanied by an increased risk of colorectal cancer (CRC). Patients fulfilling the clinical criteria, as defined by the WHO,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1924ebf2693b1e473877e17772b5536e
https://doi.org/10.1136/gutjnl-2015-310630